Worth Venture Partners, LLC Rezolute, Inc. Transaction History

Worth Venture Partners, LLC

  • $34.6 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.6 - $3.85 $239,220 - $354,230
-92,008 Reduced 87.87%
12,701 $38,000
Q1 2022

May 16, 2022
BUY
$2.27 - $5.1 $99,859 - $224,354
43,991 Added 72.45%
104,709 $354,000
Q4 2021

Feb 14, 2022
BUY
$4.21 - $7.61 $255,622 - $462,063
60,718 New
60,718 $290,000

Others Institutions Holding RZLT

# of Institutions
62
Shares Held
38.5M
Call Options Held
1.6K
Put Options Held
24.6K
View Full List

About Rezolute, Inc.

RZLT Quotes by TradingView
  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $171M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Worth Venture Partners, LLC Portfolio

Follow Worth Venture Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worth Venture Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email